Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.11.2012 | original article | Sonderheft 3/2012

Wiener klinische Wochenschrift 3/2012

Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria

Wiener klinische Wochenschrift > Sonderheft 3/2012
Lorenz Auer-Hackenberg, Stefan Winkler, Wolfgang Graninger, Nina Worel, MD Assoc. Prof. Michael Ramharter


Despite the administration of antimalarial treatment, severe malaria still has a high mortality rate. Since overall survival is associated with total parasite biomass, whole blood exchange (e.g. blood exchange transfusions) has been proposed as a potential method to rapidly reduce peripheral parasitaemia. Automated red blood cell exchange has been advocated as a physical method to remove parasites. Compared to exchange transfusion, automated red blood exchange may avoid the risk of volume alterations and haemodynamic distress. Since 1984, there have been 37 published cases in which automated red blood cell exchange was used as an adjunctive treatment in severe malaria caused by Plasmodium falciparum. This short review summarizes current evidence and discusses problems, challenges and goals for future studies and research in order to assess the clinical benefit of automated erythrocyte exchange in severe malaria cases.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Sonderheft 3/2012

Wiener klinische Wochenschrift 3/2012 Zur Ausgabe